Drug Discovery

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod

  • US
  • |
  • News

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more

gilead-leukemia-study-gets-complete-repsonse

Gilead leukemia study gets complete response


  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more

bioduro-opens-discovery-lab-in-shanghai

BioDuro opens discovery lab in Shanghai


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more

biodiem-novel-anti-microbial-bdm-1-gets-chinese-divisional-patent

BioDiem BDM-1 gets Chinese divisional patent

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicrobial compound BDM-I.... Read more

an-antidepressant-a-day-keeps-sickle-cell-disease-at-bay

Antidepressant can treat sickle cell disease

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug tranylcypromine (TCP)... Read more

aveo-oncology-and-astellas-pharma-announce-overall-survival-os-for-phase-iii-tivozanib-versus-sorafenib-study-in-advanced-renal-cell-carcinoma-rcc

Aveo, Astellas report cancer trial results

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III... Read more

good-news-for-duchenne-muscular-dystrophy-dmd-patients-daiichi-sankyo-innovation-network-corporation-of-japan-incj-and-mitsubishi-ufj-capital-to-develop-new-treatment

Daiichi forms new firm to treat muscular dystrophy

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innovation Network Corporation... Read more

australia-s-allied-healthcare-receives-iso-13485-to-progresses-in-the-regulatory-process-for-obtaining-european-ce-mark-approval-for-cardiocel

Allied to soon get CE mark approval from EU

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 2 Comments

Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approval for CardioCel,... Read more

russia-celebrates-as-its-nn-petrov-institute-of-oncology-signs-collaboration-agreement-with-astrazeneca

AstraZeneca begins cancer research in Russia

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed a research collaboration... Read more

eye-glaucoma

Singapore univ prepares for trial of glaucoma drug

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: For glaucoma patients, taking daily medication will soon become a thing of the past. With Nanyang Technological University's... Read more

draft-guidance

FDA offers guidance on Alzheimer’s drug development

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatments for patients... Read more

leigh-berryman-ceo-maccine

Changing the paradigm of drug development

  • Europe
  • |
  • Opinion
  • |
  • By Leigh Berryman
  • |
  • 0 Comment

Recent promising data on drug approvals in 2011 shows that there were 35 new molecular entities (NME) approved by the FDA. This is the largest... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X